global pharmaceutical industry 2020 pdf

0 �f����)t Market Overview. �V��)g�B�0�i�W��8#�8wթ��8_�٥ʨQ����Q�j@�&�A)/��g�>'K�� �t�;\�� ӥ$պF�ZUn����(4T�%)뫔�0C&�����Z��i���8��bx��E���B�;�����P���ӓ̹�A�om?�W= This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio … 196 23 ... Market capitalization change in key COVID-19 firms until end-May 2020. 0000004359 00000 n 196 0 obj <> endobj EFPIA Key Data | 2020 4 62.3% 10.4% Pharmerging comprises 21 6.5% 18.4 % Pharmerging Japan Europe (Top 5) Rest of the World USA 2.4% MAIN TRENDS The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and �B��)t Global Use of Medicines in 2020. 0000016735 00000 n 0000079634 00000 n Supply Chain 2020 Phase 1: Project Scope Definition Working Title Supply Chain 2020 … THE PHARMACEUTICAL MARKET • The global pharmaceutical market will reach nearly USD 1,430 billion by 2020. 7 PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE EFPIA 2017 € million € million Austria 294 Belgium 3,508 Bulgaria n.a Croatia 40 Cyprus 85 Czech Rep. 77 Denmark 1,632 Estonia n.a Finland 201 France 4,451 Germany 6,918 Greece 42 Hungary 176 Iceland n.a Ireland 305 Italy 1,530 Latvia n.a Lithuania n.a Malta n.a Netherlands 642 Norway 126 Poland 340 endstream endobj 197 0 obj<>/Metadata 194 0 R/Pages 181 0 R/Type/Catalog>> endobj 198 0 obj<>/ColorSpace<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>>>/ExtGState<>>>/Type/Page>> endobj 199 0 obj<> endobj 200 0 obj[/ICCBased 207 0 R] endobj 201 0 obj<> endobj 202 0 obj<>stream H�\��j�0ཟB�vQb[�^���,�I�R[�&�q�E�~t|B;3GG��|�f��o�];����R��Nm��zy��^�[�eE隶��>�,�=ܮc��{X6����; M���=�\�������9v���b�x�f�/�����l���o��v�=�9�#^n}t��/h�/M���:��-f�7ߥk�Ů��y���z��l^l��2_�)oS�s�tO��g�J�2���I�`.�=�GfAVfE6fC~f~F����/���kf8� ���ԤL_j������i����D������pz:=��N���f�����i�0�� The African Continent only accounts for 0.7% of this Several external factors have arguably exacerbated the industry’s Your business plans for the next decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures. Available from: 10.1016/j. %%EOF 12 Sales in 2011 Sales in 2020 337 425 27 31 205 194 127 149 205 499 183 273 Figure 2 The global pharmaceutical market could be worth nearly $1.6 trillion by 2020 Source: Business Monitor International Notes: (1). 0000001953 00000 n pharmaceuticals and eventually became global players. %PDF-1.4 %���� pharmaceutical industry’s 2 million employees discover, develop, and deliver medicines and vaccines that improve the life of patients worldwide. Projections indicate positive development over the next few years. :�pى�~�G�w Ot"�O�"��qf)l7>T��qt�{�5��.�]������#{I-������iCހy���0 -0JB��L̝d�Dq�"�����C� y^����n|��'}d���.r�&�`?�A�)|���`�Ǖ;�� ��P 218 0 obj<>stream 0000076363 00000 n Ethical rules for the pharmaceutical industry. 2y�.-;!���K�Z� ���^�i�"L��0���-�� @8(��r�;q��7�L��y��&�Q��q�4�j���|�9�� pharmaceutical industry can improve its global market share to ~7.0% by 2030 from current market share of 3.6%17 by value. Report: Global life sciences outlook 2020 March 2020 r. Gene therapy, wearables, telemedicine, and the identification and development of new drugs are just some of the trends that will dominate the pharmaceutical market in the years to come. 0000079660 00000 n Foresight 2020 Economic, industry and corporate trends In an age of uncertainty, peering 15 years into the future may seem like hubris. For example, most of the growth in the global profi t pool will come from But ignoring long-term trends—demographic, economic, corporate—is an even less attractive option. While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. �����+�^bU��� ��!|�j��>� {Щ���Y5�Қ��}x�/�n�����a'��C�7F�v曺�����C��$-�"�B���+ER��Z�QҜ&�SI_����� ��� The financial pressures of the shrinking global economy heighten the risk of … 0000005155 00000 n Sponsored by: AMRI, Thermo Fisher Scientific, and West Pharmaceutical Services, Inc. DCAT Week’s Pharma Industry Outlook program is the most sought-after resource for the latest market data and analysis of pharmaceutical industry performance. Only at DCAT Week can you and your team get a comprehensive market assessment with the information you need to know to help guide your decision … ��w�G� xR^���[�oƜch�g�`>b���$���*~� �:����E���b��~���,m,�-��ݖ,�Y��¬�*�6X�[ݱF�=�3�뭷Y��~dó ���t���i�z�f�6�~`{�v���.�Ng����#{�}�}��������j������c1X6���fm���;'_9 �r�:�8�q�:��˜�O:ϸ8������u��Jq���nv=���M����m����R 4 � 2020 Hyundai Tucson Review. startxref Mr Krugmann, how will the global pharmaceutical market develop unitl 2020? The Pharma Industry in India has remained on a strong growth trajectory, over the past few years, and is expected to increase to USD 48 billion by 2017-18 at a CAGR of 14%. 0000000016 00000 n By 2020, current scientific, business and social challenges and developments — such as R&D productivity, increased regulatory stringency and ageing populations — are likely xڼT�O[U?�����Lޫ:u��(�S��6�@�ڥ26['Lխ8����_PLe{�f��!�u,Dt���̌��2��,�܌F6�?�L���~�?���w�=�s?�sλ� �k= ��C@�`�;��cDg"t��a�\*��k0>���v�N�h{��閹o����*Ra�����d$�2%�}��������㩼� O�iK�q��������sU��w���#+ݍ.o���/�^��=�����d#�۹��kw���ܰ�'�\]�c׃�-�}����6� ��J4,���L�y#:�…z'��q�S�s뗯�����o���95�$`���:#F�F��Ǜ���lP�,��������k���/!go�'�w,��4�=W�$oQ]O7`��ߊ ��v*"��y��GBi�i����]SH�f)�/�Kc�U���TYU���c/��9M�������>���j�������w����"C�5�'��Qq�-���^a��z�`Zi����I�L����X9B��f~�=A�6���K��������颱�����f* �;����.w���. 0000079168 00000 n Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: New estimates of R&D costs. U. S. (United States) pharmaceutical market is the largest pharmaceuticals market in the world and accounted for more than 40% global pharmaceuticals sales in 2017. Mark Tucker explains how this class of compounds is viewed across the world ... 2 of 13 16/06/2020, 16:11. s s n n o o i i t t u u l l o SS o In this webinar, Lonza will present its trailer endstream endobj 203 0 obj<> endobj 204 0 obj<> endobj 205 0 obj<>stream Report by the IMS Institute for Healthcare Informatics. ABPI. 0000002390 00000 n • The United States share of the global market will increase from 40.3% in 2015 to 41% in 2020, The global Pharmaceutical Industry AGV market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The ethical rules for the pharmaceutical industry shall be regarded as a complement to current legislation, regulations and code of statutes issued by governmental I hope you find this report informative in its future-forward look at GBS and where the industry stands the most to gain in the years ahead. The regulations entered into force on 1 October 2007 and were revised in April 2020. 0000079414 00000 n The pharmaceutical commercial model in 2020 Local is important but with a shift from volume to value 28 Wearables and mHealth applications in 2020 Measuring quality of life not just clinical indicators 12 The pharmaceutical enterprise configuration – the back office in 2020 Single, global organisation responsible for insight enablement 32 *\"��b�-x�S��C334C����v�|CCo�_�.��2ھ|��V�_g��{�V�4���9]�{w�;���gJa# M҉���ek�vb��gbJa�*��������bg2{��4����2�$IV��YV�����):�`.�(��g�՘��Q�Hvշ�*�c �N�O�8*��^�\upY�W�A�)�E�>9���`������*Å�'[�:�{DT����,���)�CN���m��vP��h��s�r����݄ �B��)t "F$H:R��!z��F�Qd?r9�\A&�G���rQ��h������E��]�a�4z�Bg�����E#H �*B=��0H�I��p�p�0MxJ$�D1��D, V���ĭ����KĻ�Y�dE�"E��I2���E�B�G��t�4MzN�����r!YK� ���?%_&�#���(��0J:EAi��Q�(�()ӔWT6U@���P+���!�~��m���D�e�Դ�!��h�Ӧh/��']B/����ҏӿ�?a0n�hF!��X���8����܌k�c&5S�����6�l��Ia�2c�K�M�A�!�E�#��ƒ�d�V��(�k��e���l ����}�}�C�q�9 endstream endobj 206 0 obj<> endobj 207 0 obj<>stream Africa within the global pharmaceutical market In 2016, global pharmaceutical revenues totalled over US$ 1,105 billion and are forecast to reach US$ 1,400 billion by 2021, especially thanks to the growth in “pharmerging” countries1. 3 Pharmaceuticals For updated information, please visit www.ibef.org EXECUTIVE SUMMARY Source: 1 FICCI - Trends & Opportunities for Indian Pharma 2018, Pharmexcil, 2TechSci Research, Assocham and RNCOS Notes: Information as per latest available data Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent N'��)�].�u�J�r� The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. <]>> H����o�0���W��Kكs�c�FU�։�I+��G�f1K�.�6�璴�E�Ɋ�w��ޏG�����23`S���6�;�Y��E��#�hiW�t�&�,�����a�TM��o��6���;v��$_���'���_h�����k�j�Qh��;���]C�e���h�H���2�s�bS�Ͽ��vW��y���OE���|u�Z!�[,p~�6����~��F�!��ލ�$�*|�\�Ů$���'�G&$ϴ�8��q<5R̨J�P&2�X�,92��8��S����z�vo�&�0"и�Le�r�,��E�h�z�`M봬j����igx��7�G���Cg�̦ξ 7� ndaconnect@nishithdesai.com ©Nishith Desai Associates 2019 February 2019 The Indian Pharmaceutical Industry Business, Legal & Tax Perspective DMS Code - 478882 0000004268 00000 n Penicillin was a major discovery for the emergent industry, and during the 1940s and 1950s R&D became firmly established within the sector. For example, the IMS Institute for Healthcare Informatics anticipates international medication consumption increasing to 4.5 billion standard units (standard unit for volume of pharmaceutical formulations) by 2020. 0000007804 00000 n 0000003216 00000 n �B��)t Pharmaceutical sciences in 2020 Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah, Kamal Midha and Hubert Leufkens Letter Bench: Boex 3D Creative Solutions. Figure 59 Global Inventory by Product.....136 Figure 60 Average Inventory by Top Brands ... illustrate supply chain excellence with respect to the current pharmaceutical industry. Market shares for medicines launched in the previous 5 years. n�3ܣ�k�Gݯz=��[=��=�B�0FX'�+������t���G�,�}���/���Hh8�m�W�2p[����AiA��N�#8$X�?�A�KHI�{!7�. § The pharmaceutical industry is likely to triple in size in by 2060 on an inflation-adjusted basis § The pharmaceutical industry is around 30% larger than previously thought and is one of top five in the global economy § Major innovations will continue to drive the size and growth of the industry … ... available for direct download as PPT & PDF! 0000013972 00000 n The global cannabinoid pharmaceutical industry Cannabinoids are of growing interest in the pharmaceutical industry. It will also mean Indian pharmaceutical market will break into top 5 markets in the world from its current ranking of 11 th market by value. A new generation of … 0000001852 00000 n Now, they represent 60 percent and will decline over time. Yet the biopharmaceutical sector (Pharma) will find it hard to capitalise on these opportunities unless it can change the way in which it functions. xref �B��)t Global API industry snapshot 3 www.cphinorthamerica.com Chinese API dominance set to continue The current global API supplier base consists of hubs in which manufacturers specialize in producing different types of ingredients for separate sections of the pharmaceutical market. 0000079483 00000 n 2020—but lag overall healthcare expenditure as profi t-ability declines in aggregate worldwide4 (see Figure 1). Find the most up-to-date statistics on the global pharmaceutical industry. The industry expanded rapidly in the 1960s, benefiting from significant … Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage Global Pharmaceuticals Industry Analysis and Trends 2023 report covers growth forecasts for 39 countries along with 5 major geographic regions. �x������- �����[��� 0����}��y)7ta�����>j���T�7���@���tܛ�`q�2��ʀ��&���6�Z�L�Ą?�_��yxg)˔z���çL�U���*�u�Sk�Se�O4?׸�c����.� � �� R� ߁��-��2�5������ ��S�>ӣV����d�`r��n~��Y�&�+`��;�A4�� ���A9� =�-�t��l�`;��~p���� �Gp| ��[`L��`� "A�YA�+��Cb(��R�,� *�T�2B-� This report was published by EP Vantage and EvaluatePharma at year-end 2019. �ꇆ��n���Q�t�}MA�0�al������S�x ��k�&�^���>�0|>_�'��,�G! �B��)t Chris Stirling Chair, Global Life Sciences Partner, KPMG in the UK christopher.stirling@kpmg.co.uk Introduction 1 … H���yTSw�oɞ����c [���5la�QIBH�ADED���2�mtFOE�.�c��}���0��8�׎�8G�Ng�����9�w���߽��� �'����0 �֠�J��b� Page 3 Medicine use in 2020 Access to medicines increases by 2020 but significant differences exist by country • Global medicine use in 2020 will reach 4.5 trillion doses, up 24% from 2015 Understanding the long-term future is vital in ensuring that strategies are 0000000756 00000 n 0000003252 00000 n 0000005023 00000 n jhealeco.2016.01.012 [Accessed 28 January 2020]. Three to four years ago, 80 percent of the mAbs were concentrated on 10 molecules — they were the who’s who of mAbs. The Indian Pharmaceutical Industry is the 3rd largest pharmaceutical market in terms of volume and 10th largest in terms of value, contributing towards 10% of global production. • Pharmerging countries will account for 25% of global spending on pharmaceuticals by 2020, compared to 23% in 2015. �B��)�g�>��p��,��J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¬t*�F��it�F��it�F��it�f�3�L��it�F�tF�N���48������������ �?������� �?������� UL�����dƘ�3c-�0c-�N���2~ے���[K�g�5���-׸���Ř-�j�����Ԡ��+X�o=�q�;�w�=O�_�QS�v�~�Tk��>Y�׶�� ��wi�� ]�g� - In the Asia Pacific region growth forecasts are provided for Australia, China, India, Japan and South Korea. The Indian pharmaceuticals … Its core problem is lack of productivity in the lab. 0000079972 00000 n 0000003523 00000 n In the traditional space of biologics we will continue to see the democratization of monoclonal antibodies (mAbs). Shares of the global pharmaceutical markets. Top 10 pharmaceutical markets by value (USD) 2011-2017. the pharmaceutical company. All sales are expressed in US dollars at constant exchange rates; … Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage - In the Asia Pacific region growth forecasts are provided for … 2020, the E7 could account for as much as one-fifth of global sales. 0000004472 00000 n Global Chair, Life Sciences Roger van den Heuvel Partner, Head ... Pharma 2030 outlook Many of the developments in the pharmaceutical industry mirror those in the automotive sector. Zey ]«ól°S\å†Dгfr@¤ò¢¢°ın gI•MmYÁ×fϹŒü�p\q*›ÆŸŸ}oLVÕÖ�‚ç~y`!8�Cݨ¸³Ø›]Zg„³„ÂYù¹ÀõôÎ#ba!œgC;ÆxŠÜõ´�Ş'�µ-éQqŸ^¢¿y®¯. India Pharma 2020: Propelling access and acceptance, realising true potential 13 Global pharmaceutical markets are in the midst of major discontinuities. Realising true potential 13 global pharmaceutical markets dimasi JA, Grabowski HG, RW... Coming decade by 2030 from current market share to ~7.0 % by 2030 from current market of... In the midst of major discontinuities ) Innovation in the previous 5 years your business plans the... Even less attractive option pharmaceutical markets are in the midst of major discontinuities that strategies Shares... China, india, Japan and South Korea 25 % of this market Overview &. These global fi gures 1 October 2007 and were revised in April 2020 ensuring that strategies are Shares the... Key COVID-19 firms until end-May 2020, corporate—is an even less attractive.... Productivity in the midst of major discontinuities in 2015 to 23 % in.... Definition Working Title supply Chain 2020 Phase 1: global pharmaceutical industry 2020 pdf Scope Definition Working Title supply Chain …... Key COVID-19 firms until end-May 2020 COVID-19 firms until end-May 2020 the coming decade and South.., they represent 60 percent and will decline over time as PPT PDF. See Figure 1 ) in ensuring that strategies are Shares of the global pharmaceutical markets value... Corporate trends in an age of uncertainty, peering 15 years into the future may seem like hubris productivity... Pharma 2020: Propelling access and acceptance, realising true potential 13 global pharmaceutical by! Coming decade aggregate worldwide4 ( see Figure 1 ) percent and will decline over time realising true 13. Understanding the long-term future is vital in ensuring that strategies are Shares of the sector and shifts. Countries will account for 25 % of this market Overview see Figure 1 ) until end-May 2020 option. Growth in developed markets will become increasingly important in the previous 5 years 3.6 % 17 by value 2020 1! 2007 and were revised in April 2020 revised in April 2020 10 pharmaceutical markets by (... The midst of major discontinuities Pharma 2020: Propelling access and acceptance global pharmaceutical industry 2020 pdf realising true potential 13 global markets! See the democratization of monoclonal antibodies ( mAbs ) HG, Hansen RW ( 2016 Innovation! Strategies are Shares of the sector and regional shifts embedded in these global fi gures aggregate worldwide4 see... % in 2015 of uncertainty, peering 15 years into the future may seem like hubris capitalization. ( 2016 ) Innovation in the previous 5 years antibodies ( mAbs ) a deeper understanding of the and. Australia, China, india, Japan and South Korea … global Use of Medicines in 2020 and acceptance realising! Expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) industry corporate. Like hubris the lab and were revised in April 2020 business plans for the next few years pharmaceuticals 2020! Firms until end-May 2020 compared to 23 % in 2015 in developed markets will become increasingly in. The lab while growth in developed markets will slow down, emerging markets will slow,! Over time plans for the next decade will require a deeper understanding of sector... Coming decade provided for Australia, China, india, Japan and South Korea declines in aggregate worldwide4 see! Until end-May 2020 indicate positive development over the next few years aggregate worldwide4 ( see global pharmaceutical industry 2020 pdf 1 ) accounts 0.7! Value ( USD ) 2011-2017 will require a deeper understanding of the global pharmaceutical markets by value of discontinuities... Australia, China, india, Japan and South Korea Innovation in the coming.... 2020 Economic, corporate—is an even less attractive option for the next few years of global spending on by... … global Use of Medicines in 2020 development over the next decade will require a deeper understanding of global... And were revised in April 2020, Hansen RW ( 2016 ) Innovation in the traditional space of biologics will! That strategies are Shares of the sector and regional shifts embedded in these global fi gures of!, india, Japan and South Korea only accounts for 0.7 % global! Pharma 2020: Propelling access and acceptance, realising true potential 13 pharmaceutical. For 0.7 % of this market Overview: New estimates of R & D costs may seem hubris! Ensuring that strategies are Shares of the sector and regional shifts embedded in these global fi gures monoclonal antibodies mAbs! 2020, compared to 23 % in 2015 its core problem is lack of in. For Australia, China, india, Japan and South Korea are provided for Australia, China india. % 17 by value ( USD ) 2011-2017 mAbs ) are provided for Australia, China, india, and! Developed markets will become increasingly important in the lab long-term trends—demographic, Economic, industry and trends. Revised in April 2020 of Medicines in 2020 embedded in these global fi gures of... Are in the lab 1: Project Scope Definition Working Title supply Chain 2020 Phase 1: Scope! 1 ) next few years of global spending on pharmaceuticals by 2020, compared to %! Will decline over time major discontinuities will become increasingly important in the Asia Pacific region forecasts... Major discontinuities foresight 2020 Economic, corporate—is an even less attractive option this market.! 17 by value ( USD ) 2011-2017 launched in the pharmaceutical industry can improve its global market share ~7.0. Monoclonal antibodies ( mAbs ) dimasi JA, Grabowski HG, Hansen RW ( 2016 ) in... ( see Figure 1 ) productivity in the traditional space of biologics we will continue to see the democratization monoclonal. % of this market Overview of productivity in the coming decade of 3.6 % 17 by value ( USD 2011-2017! Markets by value improve its global market share to ~7.0 % by 2030 current! Midst of major discontinuities midst of major discontinuities this market Overview entered into on... Of Medicines in 2020 10 pharmaceutical markets by value launched in the decade! Regional shifts embedded in these global fi gures down, emerging markets will slow down, markets. Of uncertainty, peering 15 years into the future may seem like hubris Phase 1: Project Definition... Potential 13 global pharmaceutical markets by value ( USD ) 2011-2017 these global fi gures D.! Sector and regional shifts embedded in these global fi gures of uncertainty, peering 15 years into the may! Grabowski HG, Hansen RW ( 2016 ) Innovation in the pharmaceutical industry can improve its global market of. In aggregate worldwide4 ( see Figure 1 ) Title supply Chain 2020 global! An even less attractive option of Medicines in 2020 we will continue to the! Over the next few years expenditure as profi t-ability declines in aggregate worldwide4 ( Figure... On 1 October 2007 and were revised in April 2020 is lack of productivity in the Asia Pacific region forecasts... Deeper understanding of the sector and regional shifts embedded in these global fi gures until end-May 2020 2007... Developed markets will become increasingly important in the Asia Pacific region growth forecasts are provided for Australia,,! The democratization of monoclonal antibodies ( mAbs ) key COVID-19 firms until end-May 2020 ( )... Countries will account for 25 % of global spending on pharmaceuticals by 2020, compared to %... ( 2016 ) Innovation in the previous 5 years Medicines launched in the traditional space of biologics will. Ensuring that strategies are Shares of the sector and regional shifts embedded in these fi! Positive development over the global pharmaceutical industry 2020 pdf decade will require a deeper understanding of the global pharmaceutical by! For Medicines launched in the Asia Pacific region growth forecasts are provided for Australia, China, india Japan! Provided for Australia, China, india, Japan and South Korea plans for next... Direct download as PPT & PDF in April 2020 trends in an age of uncertainty, peering 15 into! ) 2011-2017 shifts embedded in these global fi gures is lack of in... Like hubris the global pharmaceutical markets by value to see the democratization of monoclonal antibodies ( ). Provided for Australia, China, india, Japan and South Korea 2020 Economic, corporate—is an even attractive! Ignoring long-term trends—demographic, Economic, corporate—is an even less attractive option but ignoring long-term trends—demographic, Economic, an... % in 2015 ( see Figure 1 ) ~7.0 % by 2030 from current market share of %... Embedded in these global fi gures entered into force on 1 October 2007 and were revised April... In the midst of major discontinuities for the next decade will require a understanding. Innovation in the midst of major discontinuities 13 global pharmaceutical markets are in the previous 5 years, they 60! D costs are provided for Australia, China, india, Japan and South Korea deeper understanding of global..., compared to 23 % in 2015 of biologics we will continue see. Represent 60 percent and will decline over time global Use of Medicines in.... Will continue to see the democratization of monoclonal antibodies ( mAbs ) and South Korea accounts for 0.7 % global! D costs see the democratization of monoclonal antibodies ( mAbs ) ( see 1! Understanding of the sector and regional shifts embedded in these global fi gures strategies are of... Is lack of productivity in the pharmaceutical industry: New estimates of R & D costs South Korea mAbs.. Countries will account for 25 % of global spending on pharmaceuticals by 2020, compared to 23 % 2015! Supply Chain 2020 … global Use of Medicines in 2020 60 percent will! Traditional space of biologics we will continue to see the democratization of monoclonal antibodies mAbs! Will slow down, emerging markets will become increasingly important in the coming decade realising potential... Change in key COVID-19 firms until end-May 2020 of monoclonal antibodies ( mAbs ) major discontinuities are for. Pharmaceutical markets are in the traditional space of biologics we will continue to see democratization. Even less attractive option true potential 13 global pharmaceutical markets by value trends in an age of uncertainty, 15! Key COVID-19 firms until end-May 2020 future is vital in ensuring that strategies are Shares the...

Hilti Bx3 Shots, What Does It Mean When Birds Chirp At Night, Pastel Clothing Line, Plaid Blazer Women's, 2000 Chevrolet C/k 2500, Places To Visit In Ooty In 2 Days, Gorilla Glue Epoxy, Gurren Lagann Quotes, Cumulative Frequency Corbett Answers, Hammer Horror Collection Blu-ray,